Clinical trial Recruiting at 1 site Observational Ages 19 and up

Effect of expiratory time constant (RCexp) on lung ventilation and blood flow in ventilated ARDS patients

Official title: The Physiological Effect of RCexp on Ventilation/Perfusion Distribution in Patients With ARDS

Run by Southeast University, China · NCT06919484 · Data updated 2026-11-12

This tests whether the expiratory time constant (RCexp) changes how air and blood are distributed in the lungs of adults with ARDS who are on mechanical ventilation.

More Acute Respiratory Distress Syndrome trials

Quick facts

Study typeObservational
Ages19 Years and up
SexAll
Enrollment60 (estimated)
SponsorSoutheast University, China
Academic / other
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedNovember 30, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedNovember 26, 2025
Trial IDNCT06919484 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with ARDS who have been on mechanical ventilation for 72 hours or less and can undergo bedside EIT monitoring are the intended participants.

Probably not a fit

Patients on ECMO, with pneumothorax, severe chest wounds that contraindicate EIT, pregnant patients, or those under legal protection are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational physiology study enrolling adult ARDS patients within 72 hours of starting mechanical ventilation. Investigators will measure each patient’s expiratory time constant (RCexp) and use bedside monitoring, including electrical impedance tomography, to map regional ventilation and perfusion during routine ventilator care. Data will compare ventilation and perfusion distribution across different RCexp values and ventilator settings to identify patterns of V/Q matching. Patients with contraindications to the monitoring techniques or conditions like pneumothorax or ECMO are excluded.

Why it matters

Potential benefit: If successful, results could help clinicians adjust expiratory timing to improve ventilation–perfusion matching and oxygenation in ventilated ARDS patients.

How similar studies have gone: Prior physiological studies using EIT have linked expiratory mechanics to regional ventilation, but the specific impact of RCexp on ventilation–perfusion matching in ARDS is not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

adult patients with ARDS receiving mechanical ventilation no more than 72 hours

Exclusion Criteria:

1. age \<18 years old
2. patient undergoing legal protection
3. contra-indications to EIT (e. g. severe chest trauma or wounds)
4. pneumothorax
5. patient undergoing ECMO
6. pregnancy

Where it's running

  • Zhongda Hospital, School of Medicine, Southeast University
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.